Estradiol Treatment in Young Postmenopausal Women with Self-reported Cognitive Complaints: Effects on Cholinergic-mediated Cognitive Performance

Overview

Journal Hum Psychopharmacol

Specialty Pharmacology

Date 2022 Feb 25

PMID 35212023

Authors

Alexander C Conley

Kimberly M Albert

Brenna C McDonald

Andrew J Saykin

Julie A Dumas

Paul A Newhouse

Affiliations

Soon will be listed here.

Abstract

Objective: Older women are at increased risk of developing Alzheimer's disease compared to men. One proposed reason is that following menopause there is a decline in estrogens. Estrogens are important for cholinergic functioning and attenuate the impact of cholinergic antagonists on cognitive performance in postmenopausal women. Self-reported or subjective cognitive complaints in middle or older age may represent a harbinger of cognitive decline and those who endorse cognitive complaints appear more likely to develop future cognitive impairment. However, the response of individuals with cognitive complaints after menopause to estrogen and the relationship to cholinergic functioning has not been investigated. This study investigated the effect of estrogen treatment using 17β-estradiol on cognitive performance following anticholinergic blockade in postmenopausal women and the relationship of this interaction with the level of self-reported (subjective) postmenopausal cognitive complaints.

Methods: Forty postmenopausal women (aged 50-60 years) completed a 3-month treatment regimen of either 1 mg oral estradiol or placebo. Participants then completed four challenge days in which they completed cognitive and behavioral tasks after one of four cholinergic antagonist drug conditions (oral mecamylamine (MECA), intravenous scopolamine, combined MECA and scopolamine, or PLC).

Results: Compared to PLC, the estradiol treated group performed worse on attention tasks under cholinergic challenge including the choice reaction time task and the critical flicker fusion task. In addition, participants who endorsed greater cognitive complaints showed reduced performance on the N-back working memory task, regardless of whether they received estradiol treatment.

Conclusions: The findings of this study indicate that estradiol treatment was unable to mitigate anticholinergic blockade in postmenopausal women with subjective cognitive complaints, and worsened performance on attention tasks. Moreover, the present study suggests that greater levels of cognitive complaints following menopause may be associated with an underlying decline in cholinergic function that may manifest as an inability to compensate during working memory tasks.

Citing Articles

Effect of estradiol with or without micronized progesterone on cholinergic-related cognitive performance in postmenopausal women.

Conley A, Vega J, Johnson J, Dumas J, Newhouse P Front Neurosci. 2024; 18:1428675.

PMID: 39184322 PMC: 11342399. DOI: 10.3389/fnins.2024.1428675.

Recent Advances in the Knowledge of the Mechanisms of Leptin Physiology and Actions in Neurological and Metabolic Pathologies.

Casado M, Collado-Perez R, Frago L, Barrios V Int J Mol Sci. 2023; 24(2).

PMID: 36674935 PMC: 9860943. DOI: 10.3390/ijms24021422.

References

Gilewski M, Zelinski E, Schaie K . The Memory Functioning Questionnaire for assessment of memory complaints in adulthood and old age. Psychol Aging. 1990; 5(4):482-90. DOI: 10.1037//0882-7974.5.4.482. View

Harlow S, Gass M, Hall J, Lobo R, Maki P, Rebar R . Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab. 2012; 97(4):1159-68. PMC: 3319184. DOI: 10.1210/jc.2011-3362. View

Sarter M, Hasselmo M, Bruno J, Givens B . Unraveling the attentional functions of cortical cholinergic inputs: interactions between signal-driven and cognitive modulation of signal detection. Brain Res Brain Res Rev. 2005; 48(1):98-111. DOI: 10.1016/j.brainresrev.2004.08.006. View

Dumas J, Hancur-Bucci C, Naylor M, Sites C, Newhouse P . Estradiol interacts with the cholinergic system to affect verbal memory in postmenopausal women: evidence for the critical period hypothesis. Horm Behav. 2007; 53(1):159-69. PMC: 2435492. DOI: 10.1016/j.yhbeh.2007.09.011. View

Beam C, Kaneshiro C, Jang J, Reynolds C, Pedersen N, Gatz M . Differences Between Women and Men in Incidence Rates of Dementia and Alzheimer's Disease. J Alzheimers Dis. 2018; 64(4):1077-1083. PMC: 6226313. DOI: 10.3233/JAD-180141. View

Smith Y, Minoshima S, Kuhl D, Zubieta J . Effects of long-term hormone therapy on cholinergic synaptic concentrations in healthy postmenopausal women. J Clin Endocrinol Metab. 2001; 86(2):679-84. DOI: 10.1210/jcem.86.2.7222. View

Young J, Shytle R, Sanberg P, George T . Mecamylamine: new therapeutic uses and toxicity/risk profile. Clin Ther. 2001; 23(4):532-65. DOI: 10.1016/s0149-2918(01)80059-x. View

Oveisgharan S, Arvanitakis Z, Yu L, Farfel J, Schneider J, Bennett D . Sex differences in Alzheimer's disease and common neuropathologies of aging. Acta Neuropathol. 2018; 136(6):887-900. PMC: 6279593. DOI: 10.1007/s00401-018-1920-1. View

Beck A, Ward C, Mendelson M, Mock J, ERBAUGH J . An inventory for measuring depression. Arch Gen Psychiatry. 1961; 4:561-71. DOI: 10.1001/archpsyc.1961.01710120031004. View

10.

Gibbs R, Chipman A, Hammond R, Nelson D . Galanthamine plus estradiol treatment enhances cognitive performance in aged ovariectomized rats. Horm Behav. 2011; 60(5):607-16. PMC: 3210334. DOI: 10.1016/j.yhbeh.2011.08.010. View

11.

Yamamoto H, Kitawaki J, Kikuchi N, Okubo T, Iwasa K, Kawata M . Effects of estrogens on cholinergic neurons in the rat basal nucleus. J Steroid Biochem Mol Biol. 2007; 107(1-2):70-9. DOI: 10.1016/j.jsbmb.2007.03.035. View

12.

Ballinger E, Ananth M, Talmage D, Role L . Basal Forebrain Cholinergic Circuits and Signaling in Cognition and Cognitive Decline. Neuron. 2016; 91(6):1199-1218. PMC: 5036520. DOI: 10.1016/j.neuron.2016.09.006. View

13.

Folstein M, Folstein S, McHugh P . "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12(3):189-98. DOI: 10.1016/0022-3956(75)90026-6. View

14.

Dumas J, Hancur-Bucci C, Naylor M, Sites C, Newhouse P . Estrogen treatment effects on anticholinergic-induced cognitive dysfunction in normal postmenopausal women. Neuropsychopharmacology. 2006; 31(9):2065-78. DOI: 10.1038/sj.npp.1301042. View

15.

Hindmarch I . Psychological performance models as indicators of the effects of hypnotic drugs on sleep. Psychopharmacology Suppl. 1984; 1:58-68. DOI: 10.1007/978-3-642-69659-6_4. View

16.

Conley A, Albert K, Boyd B, Kim S, Shokouhi S, McDonald B . Cognitive complaints are associated with smaller right medial temporal gray-matter volume in younger postmenopausal women. Menopause. 2020; 27(11):1220-1227. PMC: 9153070. DOI: 10.1097/GME.0000000000001613. View

17.

Ebert U, Grossmann M, Oertel R, Gramatte T, Kirch W . Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effects of scopolamine in healthy volunteers. J Clin Pharmacol. 2001; 41(1):51-60. DOI: 10.1177/00912700122009836. View

18.

Guillem K, Bloem B, Poorthuis R, Loos M, Smit A, Maskos U . Nicotinic acetylcholine receptor β2 subunits in the medial prefrontal cortex control attention. Science. 2011; 333(6044):888-91. DOI: 10.1126/science.1207079. View

19.

Henderson V, St John J, Hodis H, McCleary C, Stanczyk F, Shoupe D . Cognitive effects of estradiol after menopause: A randomized trial of the timing hypothesis. Neurology. 2016; 87(7):699-708. PMC: 4999165. DOI: 10.1212/WNL.0000000000002980. View

20.

Green A, Ellis K, Ellis J, Bartholomeusz C, Ilic S, Croft R . Muscarinic and nicotinic receptor modulation of object and spatial n-back working memory in humans. Pharmacol Biochem Behav. 2005; 81(3):575-84. DOI: 10.1016/j.pbb.2005.04.010. View